Hamps Bio Limited discloses KMP contact details for materiality

1 min read     Updated on 06 Jul 2026, 08:18 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Hamps Bio Limited has disclosed the contact details of its Key Managerial Personnel (KMP) authorized to determine the materiality of events and make disclosures to stock exchanges. The list includes the Managing Director, Whole-time Director, Chief Financial Officer, and Company Secretary. This notification was submitted to BSE Limited on July 06, 2026.

powered bylight_fuzz_icon
44894893

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited has informed the stock exchanges regarding the contact details of its Key Managerial Personnel (KMP) designated to determine the materiality of events and information for disclosure purposes. The disclosure, made to BSE Limited on July 06, 2026, identifies the specific executives authorized for these regulatory functions under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company has appointed four senior officials to handle materiality assessments and subsequent disclosures. Hamps Bio Limited specified that these individuals are the primary points of contact for regulatory communication.

Key Managerial Personnel

The following table outlines the designated KMPs and their respective roles within the organization:

Sr. No. Name of KMP Designation Contact Details
1 Mr. Herrik Mountbaton Shah Managing Director Hamps Bio Limited, Registered Office: 2900/112, G.I.D.C. Near Atul Limited, Bharuch, Ankleshwar, Gujarat, India, 393002; Corporate Office: Plot No C1 -B -106, Nr - Mama Bhanja Factory Bhatpore GIDC, Bhatpore, Surat
2 Mr. Shrennikumar Mountkumar Shah Whole-time Director
3 Mrs. Mitali Shrennikumar Shah Chief Financial Officer
4 Mr. Ravi Baheti Company Secretary & Compliance Officer Choryasi, Gujarat, India, 394510; Email: hamps.bio@gmail.com ; Telephone: 8000001113, 8000006663

The company operates two manufacturing units. Unit-1 is located at 2900/112, G.I.D.C. Industrial Estate, Nr. Atul Ltd., Ankleshwar - 393002, while Unit-2 is situated at Plot No. C1-B-106, Nr- Mama Bhanja Factory, Bhatpore G.I.D.C., Surat, Gujarat, India 394510. The official communication channels for the company include the email address hamps.bio@gmail.com and the website www.hampsbio.com .

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+2.10%+45.75%+35.10%-48.40%

What upcoming material events or strategic announcements can be expected from Hamps Bio Limited following this regulatory compliance update?

How will the appointment of these specific KMPs influence the company's transparency and investor communication strategy moving forward?

Are there any potential expansions or operational changes planned for the two manufacturing units in Ankleshwar and Surat?

Hamps Bio reports consolidated net loss of ₹73.87 lakh in FY26

2 min read     Updated on 30 May 2026, 12:04 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Hamps Bio Limited reported a consolidated net loss of ₹73.87 lakh for the financial year ended March 31, 2026, compared to a net profit of ₹29.77 lakh in the previous year. Revenue from operations increased to ₹880.67 lakh. The board approved the audited standalone and consolidated financial results and appointed Naviwala & Associates as the internal auditor for FY27.

powered bylight_fuzz_icon
41268518

*this image is generated using AI for illustrative purposes only.

Hamps Bio Limited reported a consolidated net loss of ₹73.87 lakh for the financial year ended March 31, 2026, compared to a net profit of ₹29.77 lakh in the previous year. The company's board approved the audited standalone and consolidated financial results for the half-year and year ended March 31, 2026, at a meeting held on May 29, 2026. Revenue from operations for the year increased to ₹880.67 lakh from ₹681.98 lakh in FY25. The statutory auditor, MGHVS & Associates, issued an unmodified opinion on the financial results.

The standalone financial results showed a net loss of ₹65.49 lakh for FY26, a significant decline from the net profit of ₹29.77 lakh recorded in the previous year. Total income for the standalone entity rose to ₹884.86 lakh from ₹681.98 lakh in the prior year. The board also approved the appointment of Naviwala & Associates, Surat, as the internal auditor for the financial year 2026-2027, effective from May 29, 2026.

Financial Performance

The company's total expenses increased to ₹950.65 lakh in FY26 from ₹641.60 lakh in the previous year. Finance costs for the year stood at ₹24.88 lakh, while depreciation and amortization expenses were ₹81.68 lakh. The basic earnings per share (EPS) for the year was reported at (₹0.85), compared to ₹0.68 in FY25. The company issued bonus shares in the ratio of 1:1 during the year, and EPS figures have been adjusted retrospectively.

Consolidated vs Standalone Results

The consolidated results include the financials of HSDL Innovative Private Limited, which became a wholly owned subsidiary on March 25, 2026. Consequently, the comparative figures for the previous year represent standalone figures of the parent company. The consolidated revenue from operations for FY26 was ₹847.46 lakh, with a total income of ₹880.67 lakh. The consolidated net loss after tax for the year was ₹73.87 lakh.

Key Financial Metrics

Metric FY26 (₹ in Lakhs) FY25 (₹ in Lakhs)
Consolidated Revenue from Operations 847.46 666.87
Consolidated Total Income 880.67 681.98
Consolidated Net Profit/(Loss) (73.87) 29.77
Standalone Revenue from Operations 851.65 666.87
Standalone Total Income 884.86 681.98
Standalone Net Profit/(Loss) (65.49) 29.77

The intimation was submitted to BSE Limited in compliance with Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board meeting commenced at 4:00 PM IST and concluded at 6:30 PM IST.

Historical Stock Returns for Hamps Bio

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%+2.10%+45.75%+35.10%-48.40%

What specific factors drove the 48% increase in total expenses that offset the revenue growth?

How does the company plan to leverage the newly acquired subsidiary, HSDL Innovative Private Limited, to restore profitability?

What strategic initiatives will be implemented to manage the rising finance costs and depreciation expenses?

More News on Hamps Bio

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+35.10%